Phibro Animal Health Corp (PAHC): Cost of Revenue
$1.01B
Year ended 2026-06-30
+13.9%
3-year compound annual growth
+12.3%
5-year compound annual growth
+7.0%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.01B | +12.2% | 2026-08-26, From 2025-07-01 |
| 2025-06-30 | $896.27M | +27.2% | 2026-08-26, From 2024-07-01 |
| 2024-06-30 | $704.59M | +3.7% | 2026-08-26, From 2023-07-01 |
| 2023-06-30 | $679.65M | +3.5% | 2025-08-27, From 2022-07-01 |
| 2022-06-30 | $656.86M | +16.9% | 2024-08-28, From 2021-07-01 |
| 2021-06-30 | $561.97M | +3.4% | 2023-08-30, From 2020-07-01 |
| 2020-06-30 | $543.47M | -3.5% | 2022-08-24, From 2019-07-01 |
| 2019-06-30 | $563.37M | +1.9% | 2021-08-25, From 2018-07-01 |
| 2018-06-30 | $553.10M | +7.2% | 2020-08-26, From 2017-07-01 |
| 2017-06-30 | $516.04M | +0.7% | 2019-08-27, From 2016-07-01 |
| 2016-06-30 | $512.49M | -0.5% | 2018-08-27, From 2015-07-01 |
| 2015-06-30 | $515.31M | +5.7% | 2017-08-30, From 2014-07-01 |
| 2014-06-30 | $487.50M | +2.8% | 2016-08-29, From 2013-07-01 |
| 2013-06-30 | $474.19M | -3.2% | 2015-09-10, From 2012-07-01 |
| 2012-06-30 | $489.96M | n/a | 2014-09-18, From 2011-07-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.01B | +12.2% |
| Alkermes plc. (ALKS) | 2025-12-31 | $196.46M | -19.9% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $246.00M | +6.5% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $493.13M | -2.0% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $89.00M | +8.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $25.50M | n/a |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $15.91M | +41.9% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $198.34M | +26.5% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $317.31M | +24.9% |
Compare PAHC, ALKS, INDV, PBH side by side · Screen every company in Pharmaceutical Preparations ↗